US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
AMEX
Citigroup Fdg (CTH)
Citigroup Fdg (CTH) ニュース

CTH

Citigroup Fdg (CTH)

Citigroup Fdg

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:CTH

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2016/08/15	19 : 00	GlobeNewswire	Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...	AMEX:CTH	Citigroup Fdg
2016/07/19	05 : 10	GlobeNewswire	Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...	AMEX:CTH	Citigroup Fdg
2016/06/30	21 : 00	GlobeNewswire	Cynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...	AMEX:CTH	Citigroup Fdg
2016/05/30	15 : 00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
2016/04/15	19 : 00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
2015/12/08	16 : 00	GlobeNewswire	Cynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...	AMEX:CTH	Citigroup Fdg
2014/07/18	05 : 15	GlobeNewswire	Cynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States	AMEX:CTH	Citigroup Fdg
2014/07/08	14 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...	AMEX:CTH	Citigroup Fdg
2014/05/14	19 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...	AMEX:CTH	Citigroup Fdg
2014/04/24	19 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
2014/03/28	19 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...	AMEX:CTH	Citigroup Fdg
2014/01/13	20 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277	AMEX:CTH	Citigroup Fdg
2013/05/15	14 : 00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
2006/03/25	01 : 00	PR Newswire (US)	American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.	AMEX:CTH

Showing the most relevant articles for your search:AMEX:CTH

1

Bank of America

Health Care Select Sector

Energy Select Sector SPDR

US Dollar vs Yen

Invesco QQQ Trust Series 1

American Express

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約